Gecacitinib
Drug timelines are a Plus or Pro feature.
12 regulatory and trial events tracked for Gecacitinib, covering 2025-06-10 to 2026-03-17. Get the full timeline:
Most recent: Clinical Trial Update: Gecacitinib in the Treatment of Steroid-Refractory/Dependent Chronic Graf Versus Host Disease (cGVHD). [Phase 1, Phase 2]